US Stock MarketDetailed Quotes

Centessa Pharmaceuticals (CNTA)

Watchlist
  • 39.470
  • +0.040+0.10%
Close Apr 24 15:59 ET
  • 39.470
  • 0.0000.00%
Post 16:10 ET
6.10BMarket Cap-27.03P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Centessa Pharmaceuticals (CNTA) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-36.44%-193.82M
-30.39%-55.81M
-172.63%-58.31M
44.67%-22.45M
-53.53%-57.25M
11.40%-142.06M
-37.84%-42.8M
42.80%-21.39M
7.90%-40.58M
22.06%-37.29M
Net income from continuing operations
16.21%-197.53M
40.57%-66.16M
-28.96%-54.89M
-14.90%-50.34M
31.31%-26.14M
-56.04%-235.76M
-202.22%-111.33M
-10.14%-42.57M
-76.07%-43.82M
24.98%-38.05M
Operating gains losses
----
----
----
----
----
--34.1M
----
----
----
----
Depreciation and amortization
-2.23%921K
4.78%241K
0.42%237K
-4.24%226K
-9.58%217K
16.30%942K
-6.50%230K
-0.84%236K
-0.42%236K
169.66%240K
Deferred tax
-5.43%2.51M
-41.46%233K
-79.67%255K
80.95%1.03M
129.26%995K
110.00%2.65M
367.11%398K
143.39%1.25M
102.41%567K
--434K
Other non cash items
1,750.00%1.15M
261.31%271K
--271K
--190K
--415K
121.43%62K
-150.75%-168K
----
----
----
Change In working capital
-235.83%-30.02M
-95.15%1.23M
-195.43%-11.26M
415.63%18.55M
-320.36%-38.54M
217.20%22.1M
851.38%25.34M
365.50%11.8M
-21.55%-5.88M
-47.80%-9.17M
-Change in receivables
-9.94%-7.26M
69.23%-3.72M
-201.42%-9.98M
293.07%10.73M
-454.26%-4.28M
45.41%-6.6M
-52.43%-12.1M
523.90%9.84M
9.49%-5.56M
-71.92%1.21M
-Change in prepaid assets
-176.84%-7.85M
-232.37%-5.94M
-198.08%-3.94M
414.66%4.7M
-183.31%-2.68M
849.19%10.22M
143.04%4.49M
261.77%4.01M
17.23%-1.49M
199.07%3.21M
-Change in payables and accrued expense
-183.39%-15.17M
-67.06%10.83M
221.93%2.59M
178.25%3.06M
-131.58%-31.65M
616.79%18.19M
1,150.08%32.88M
-1,023.91%-2.13M
-78.88%1.1M
-17.97%-13.67M
-Change in other current assets
-15.10%253K
-15.07%62K
-14.86%63K
-16.00%63K
-14.47%65K
115.83%298K
-14.12%73K
-41.27%74K
103.58%75K
--76K
Cash from discontinued investing activities
Operating cash flow
-36.44%-193.82M
-30.39%-55.81M
-172.63%-58.31M
44.67%-22.45M
-53.53%-57.25M
11.40%-142.06M
-37.84%-42.8M
42.80%-21.39M
7.90%-40.58M
22.06%-37.29M
Investing cash flow
Cash flow from continuing investing activities
-1,438.57%-418.53M
-972.54%-218.13M
37.77%61.95M
27.96%-39.95M
-1,426.74%-222.39M
124.62%31.27M
236.80%25M
-7.68%44.96M
22.00%-55.46M
119.41%16.76M
Net PPE purchase and sale
-991.18%-371K
---11K
-588.24%-234K
----
----
79.88%-34K
--0
20.93%-34K
--0
--0
Net investment purchase and sale
-1,435.93%-418.16M
-972.49%-218.12M
38.18%62.18M
28.18%-39.83M
-1,426.74%-222.39M
124.68%31.3M
237.01%25M
-7.69%45M
21.99%-55.46M
119.43%16.76M
Cash from discontinued investing activities
Investing cash flow
-1,438.57%-418.53M
-972.54%-218.13M
37.77%61.95M
27.96%-39.95M
-1,426.74%-222.39M
124.62%31.27M
236.80%25M
-7.68%44.96M
22.00%-55.46M
119.41%16.76M
Financing cash flow
Cash flow from continuing financing activities
-20.08%291.53M
9,464.63%283.4M
-98.60%3.44M
-98.48%1.61M
-70.59%3.09M
1,627.29%364.75M
-53.42%2.96M
1,568.36%245.98M
877,508.33%105.31M
10.49M
Net issuance payments of debt
--0
----
----
----
----
---762K
----
----
----
----
Net common stock issuance
-23.43%275.36M
897,596.67%269.25M
--0
--0
-36.73%6.11M
1,628.29%359.61M
-100.48%-30K
1,566.49%242.71M
--107.27M
--9.66M
Proceeds from stock option exercised by employees
90.27%21.36M
168.29%14.33M
-16.09%3.56M
112.59%1.71M
110.38%1.76M
3,521.61%11.23M
4,427.12%5.34M
2,258.33%4.25M
6,583.33%802K
--838K
Net other financing activities
2.37%-5.19M
88.59%-181K
87.11%-125K
---100K
---4.79M
---5.32M
---1.59M
---970K
----
----
Cash from discontinued financing activities
Financing cash flow
-20.08%291.53M
9,464.63%283.4M
-98.60%3.44M
-98.48%1.61M
-70.59%3.09M
1,627.29%364.75M
-53.42%2.96M
1,568.36%245.98M
877,508.33%105.31M
--10.49M
Net cash flow
Beginning cash position
199.32%383.22M
-87.14%50.81M
-65.27%44.24M
-11.05%105.16M
199.32%383.22M
-67.48%128.03M
130.34%395.03M
-12.29%127.37M
-54.53%118.22M
-67.48%128.03M
Current changes in cash
-226.32%-320.82M
163.75%9.46M
-97.38%7.07M
-755.61%-60.8M
-2,656.93%-276.55M
195.39%253.96M
65.47%-14.84M
934.45%269.56M
108.05%9.27M
92.52%-10.03M
Effect of exchange rate changes
-136.51%-448K
-44.49%1.68M
73.69%-501K
5.83%-113K
-792.69%-1.52M
99.51%1.23M
701.59%3.03M
-965.45%-1.9M
-131.50%-120K
-57.72%219K
End cash Position
-83.83%61.95M
-83.83%61.95M
-87.14%50.81M
-65.27%44.24M
-11.05%105.16M
199.32%383.22M
199.32%383.22M
130.34%395.03M
-12.29%127.37M
-54.53%118.22M
Free cash flow
-36.67%-194.19M
-30.42%-55.82M
-173.29%-58.55M
44.36%-22.58M
-53.53%-57.25M
11.48%-142.09M
-37.72%-42.8M
42.77%-21.42M
7.92%-40.58M
22.20%-37.29M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -36.44%-193.82M-30.39%-55.81M-172.63%-58.31M44.67%-22.45M-53.53%-57.25M11.40%-142.06M-37.84%-42.8M42.80%-21.39M7.90%-40.58M22.06%-37.29M
Net income from continuing operations 16.21%-197.53M40.57%-66.16M-28.96%-54.89M-14.90%-50.34M31.31%-26.14M-56.04%-235.76M-202.22%-111.33M-10.14%-42.57M-76.07%-43.82M24.98%-38.05M
Operating gains losses ----------------------34.1M----------------
Depreciation and amortization -2.23%921K4.78%241K0.42%237K-4.24%226K-9.58%217K16.30%942K-6.50%230K-0.84%236K-0.42%236K169.66%240K
Deferred tax -5.43%2.51M-41.46%233K-79.67%255K80.95%1.03M129.26%995K110.00%2.65M367.11%398K143.39%1.25M102.41%567K--434K
Other non cash items 1,750.00%1.15M261.31%271K--271K--190K--415K121.43%62K-150.75%-168K------------
Change In working capital -235.83%-30.02M-95.15%1.23M-195.43%-11.26M415.63%18.55M-320.36%-38.54M217.20%22.1M851.38%25.34M365.50%11.8M-21.55%-5.88M-47.80%-9.17M
-Change in receivables -9.94%-7.26M69.23%-3.72M-201.42%-9.98M293.07%10.73M-454.26%-4.28M45.41%-6.6M-52.43%-12.1M523.90%9.84M9.49%-5.56M-71.92%1.21M
-Change in prepaid assets -176.84%-7.85M-232.37%-5.94M-198.08%-3.94M414.66%4.7M-183.31%-2.68M849.19%10.22M143.04%4.49M261.77%4.01M17.23%-1.49M199.07%3.21M
-Change in payables and accrued expense -183.39%-15.17M-67.06%10.83M221.93%2.59M178.25%3.06M-131.58%-31.65M616.79%18.19M1,150.08%32.88M-1,023.91%-2.13M-78.88%1.1M-17.97%-13.67M
-Change in other current assets -15.10%253K-15.07%62K-14.86%63K-16.00%63K-14.47%65K115.83%298K-14.12%73K-41.27%74K103.58%75K--76K
Cash from discontinued investing activities
Operating cash flow -36.44%-193.82M-30.39%-55.81M-172.63%-58.31M44.67%-22.45M-53.53%-57.25M11.40%-142.06M-37.84%-42.8M42.80%-21.39M7.90%-40.58M22.06%-37.29M
Investing cash flow
Cash flow from continuing investing activities -1,438.57%-418.53M-972.54%-218.13M37.77%61.95M27.96%-39.95M-1,426.74%-222.39M124.62%31.27M236.80%25M-7.68%44.96M22.00%-55.46M119.41%16.76M
Net PPE purchase and sale -991.18%-371K---11K-588.24%-234K--------79.88%-34K--020.93%-34K--0--0
Net investment purchase and sale -1,435.93%-418.16M-972.49%-218.12M38.18%62.18M28.18%-39.83M-1,426.74%-222.39M124.68%31.3M237.01%25M-7.69%45M21.99%-55.46M119.43%16.76M
Cash from discontinued investing activities
Investing cash flow -1,438.57%-418.53M-972.54%-218.13M37.77%61.95M27.96%-39.95M-1,426.74%-222.39M124.62%31.27M236.80%25M-7.68%44.96M22.00%-55.46M119.41%16.76M
Financing cash flow
Cash flow from continuing financing activities -20.08%291.53M9,464.63%283.4M-98.60%3.44M-98.48%1.61M-70.59%3.09M1,627.29%364.75M-53.42%2.96M1,568.36%245.98M877,508.33%105.31M10.49M
Net issuance payments of debt --0-------------------762K----------------
Net common stock issuance -23.43%275.36M897,596.67%269.25M--0--0-36.73%6.11M1,628.29%359.61M-100.48%-30K1,566.49%242.71M--107.27M--9.66M
Proceeds from stock option exercised by employees 90.27%21.36M168.29%14.33M-16.09%3.56M112.59%1.71M110.38%1.76M3,521.61%11.23M4,427.12%5.34M2,258.33%4.25M6,583.33%802K--838K
Net other financing activities 2.37%-5.19M88.59%-181K87.11%-125K---100K---4.79M---5.32M---1.59M---970K--------
Cash from discontinued financing activities
Financing cash flow -20.08%291.53M9,464.63%283.4M-98.60%3.44M-98.48%1.61M-70.59%3.09M1,627.29%364.75M-53.42%2.96M1,568.36%245.98M877,508.33%105.31M--10.49M
Net cash flow
Beginning cash position 199.32%383.22M-87.14%50.81M-65.27%44.24M-11.05%105.16M199.32%383.22M-67.48%128.03M130.34%395.03M-12.29%127.37M-54.53%118.22M-67.48%128.03M
Current changes in cash -226.32%-320.82M163.75%9.46M-97.38%7.07M-755.61%-60.8M-2,656.93%-276.55M195.39%253.96M65.47%-14.84M934.45%269.56M108.05%9.27M92.52%-10.03M
Effect of exchange rate changes -136.51%-448K-44.49%1.68M73.69%-501K5.83%-113K-792.69%-1.52M99.51%1.23M701.59%3.03M-965.45%-1.9M-131.50%-120K-57.72%219K
End cash Position -83.83%61.95M-83.83%61.95M-87.14%50.81M-65.27%44.24M-11.05%105.16M199.32%383.22M199.32%383.22M130.34%395.03M-12.29%127.37M-54.53%118.22M
Free cash flow -36.67%-194.19M-30.42%-55.82M-173.29%-58.55M44.36%-22.58M-53.53%-57.25M11.48%-142.09M-37.72%-42.8M42.77%-21.42M7.92%-40.58M22.20%-37.29M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------